TENORMIN Tablets

Active ingredients: Atenolol

Product name and form

Tenormin 100 mg Tablets.

Pharmaceutical Form

Film-coated tablet. White, round, biconvex, film-coated tablets of diameter 10 mm, which are intagliated with 100 on one face and bisected on the reverse face. The bisection is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

Qualitative and quantitative composition

Atenolol 100 mg.

For the full list of excipients, see section 6.1.

Active Ingredient
Description

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.

List of Excipients

Gelatin
Glycerol
Heavy Magnesium Carbonate
Magnesium Stearate
Maize Starch
Hypromellose
Sodium Laurilsulfate
Titanium Dioxide (E171)

Pack sizes and marketing

Aluminium PVC blister strips of 14 tablets in cartons: 28 Tablets.

Aluminium PVC blister strips of 7 tablets: 504 Tablets (for Hospital Use) (pack is subdivided into 6 cartons each containing 12 blister strips i.e. 84 tablets).

Marketing authorization holder

AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK

Marketing authorization dates and numbers

PL 17901/0054

Date of first authorisation: 1st June 2000

Date of latest renewal: 5th November 2003

Drugs

Drug
Countries
Austria, Australia, Canada, Cyprus, Germany, Spain, Hong Kong, Italy, Singapore, United Kingdom, United States